Uploaded February 2023 | Updated November 2026, 1 day ago
Based on case studies presented in doi.org/10.1002/pro.4482
00:00: Intro to PD-1/PD-L1
01:45: Exploring PDB ID 5jxe - Structure Summary page
04:35 How Pembrolizumab Disrupts PD-1:PD-L1 Binding
05:40 Compare structures
07:28 Other Therapeutic Anti-PD-1 Antibodies
Learn more about Pembrolizumab (pdb101.rcsb.org/motm/204) and other cancer therapy approaches on PDB-101 (pdb101.rcsb.org/).
Based on case studies presented in doi.org/10.1002/pro.4482
00:00: Intro to PD-1/PD-L1
01:45: Exploring PDB ID 5jxe - Structure Summary page
04:35 How Pembrolizumab Disrupts PD-1:PD-L1 Binding
05:40 Compare structures
07:28 Other Therapeutic Anti-PD-1 Antibodies
Learn more about Pembrolizumab (pdb101.rcsb.org/motm/204) and other cancer therapy approaches on PDB-101 (pdb101.rcsb.org/).










